The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Myeloid-derived-suppressor cells as regulators of the immune system
Open accessAbstract
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells that expand during cancer, inflammation and infection, and that have a remarkable ability to suppress T-cell responses. These cells constitute a unique component of the immune system that regulates immune responses in healthy individuals and in the context of various diseases. In this Review, we discuss the origin, mechanisms of expansion and suppressive functions of MDSCs, as well as the potential to target these cells for therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD11b+Gr1+ myeloid cells are a heterogeneous group with previously identified roles in tumor angiogenesis and T cell immunosuppression (Gabrilovich and Nagaraj, 2009; Ostrand-Rosenberg and Sinha, 2009; Shojaei et al., 2007).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Gabrilovich and Nagaraj, 2009
In the citing paper
“MDSCs play a role in the immune system through their suppressive action on T cells (116).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [116]
In the citing paper
“Through different mediators such as arginase 1, Inducible nitric oxide synthase (iNOS), reactive oxygen species (ROS), and peroxynitrite, MDSCs attenuate the activity of Teffs and NK cells (Gabrilovich and Nagaraj, 2009), regulate the differentiation of Tregs (Huang et al., 2006), and induce an immunosuppressive phenotype in macrophages (Sinha et al., 2007).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Gabrilovich and Nagaraj, 2009
In the citing paper
“On a similar note, immunosuppressive myeloid cells can be differentiated/polarized for anti‐tumor phenotypes [88, 89].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“In addition, TAMs produce several cytokines (reviewed in Ref”
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 1×
“MDSCs express high levels of both arginase 1 and iNOS, and a direct role for both of these enzymes in the inhibition of T-cell function is well established; this has been reviewed recentl”
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J., Nagaraj, S., Collazo, M. M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citationThe role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · cited 1×
“However,as these non-immunological aspects of MDSC biology have recently been reviewed elsewher”
Reactive oxygen species: role in the development of cancer and various chronic conditions.
Waris, G., & Ahsan, H. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-14 · Cited by 1,447
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435 · cited 1×
“, CD115 (also known as macrophage colony-stimulating factor receptor (M-CSF) and CSF1”
Movahedi, K., Guilliams, M., van den Bossche, J., den Bergh, R. V., Gysemans, C., Beschin, A., Baetselier, P. D., & Ginderachter, J. V. V. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,352
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citationDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E. S., Cole, D. J., & Montero, A. J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,217
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Писарев, В. М., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J. P., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,176
Self-citation
Flagged first, then by citations
1 of the 133 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Fricke, I. et al. Treatment of cancer patients with VEGF-Trap overcomes defects in DC differentiation but is insufficient to improve antigen-specific immune responses. Clin. Cancer Res. 13, 4840–4848 (2007). · DOI
Cited by
Sorted by citations
Items 201–300 of 1,053
Mechanistic links between COPD and lung cancer
Houghton, A. M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3477 · Cited by 428
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
Zhang, T., Yin, C., Fedorov, A., Qiao, L., Bao, H., Beknazarov, N., Wang, S., Gautam, A., Williams, R. M., Crawford, J. C., et al. (2022) · Nature · doi:10.1038/s41586-022-04753-7 · Cited by 420
2011: the immune hallmarks of cancer
Cavallo, F., Giovanni, C. D., Nanni, P., Forni, G., & Lollini, P. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0968-0 · Cited by 479
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 418
Self-citationNeutrophils dominate the immune cell composition in non-small cell lung cancer
Kargl, J., Busch, S., Yang, G. H. Y., Kim, K.-H., Hanke, M. L., Metz, H. E., Hubbard, J. J., Lee, S. M., Madtes, D. K., McIntosh, M. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms14381 · Cited by 413
Demand-adapted regulation of early hematopoiesis in infection and inflammation
Takizawa, H., Boettcher, S., & Manz, M. G. (2012) · Blood · doi:10.1182/blood-2011-12-380113 · Cited by 420
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
Yin, H., Zhang, X., Yang, P., Zhang, X., Peng, Y., Li, D., Yu, Y., Wu, Y., Wang, Y., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21514-8 · Cited by 412
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E. (2012) · BioMed Research International · doi:10.1155/2013/187204 · Cited by 414
Il-23 secreted by myeloid cells drives castration-resistant prostate cancer
Calcinotto, A., Spataro, C., Zagato, E., Di Mitri, D., Gil, V., Crespo, M., De Bernardis, G., Losa, M., Mirenda, M., Pasquini, E., et al. (2018) · Nature · doi:10.1038/s41586-018-0266-0 · Cited by 394
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
Sang, W., Zhang, Z., Dai, Y., & Chen, X. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00896e · Cited by 409
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kiéda, C., Janji, B., & Chouaı̈b, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 420
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398
Baek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
Mechanisms of Resistance to PD-1 and PD-L1 Blockade
Nowicki, T. S., Hu‐Lieskovan, S., & Ribas, A. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000303 · Cited by 408
Macrophage polarization and plasticity in health and disease
Biswas, S. K., Chittezhath, M., Shalova, I. N., & Lim, J.-Y. (2012) · Immunologic Research · doi:10.1007/s12026-012-8291-9 · Cited by 406
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance
David, J. M., Dominguez, C. L., Hamilton, D. H., & Palena, C. (2016) · Vaccines · doi:10.3390/vaccines4030022 · Cited by 408
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Yang, J., Xu, J., Wang, W. T., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 412
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Xu, M., Wang, Y., Xia, R., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13115 · Cited by 382
The chemokine system in cancer biology and therapy
Mantovani, A., Savino, B., Locati, M., Zammataro, L. A., Allavena, P., & Bonecchi, R. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.007 · Cited by 407
Görgün, G., Whitehill, G., Anderson, J. L., Hideshima, T., Maguire, C., Laubach, J. P., Raje, N. S., Munshi, N. C., Richardson, P. G. G., & Anderson, K. C. (2013) · Blood · doi:10.1182/blood-2012-08-448548 · Cited by 394
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Di Mitri, D., Toso, A., Chen, J. J., Sarti, M., Pinton, S., Jost, T. R., D’Antuono, R., Montani, E., Garcia-Escudero, R., Guccini, I., et al. (2014) · Nature · doi:10.1038/nature13638 · Cited by 388
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis
Gkretsi, V., & Stylianopoulos, T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00145 · Cited by 404
Targeting the bone marrow microenvironment in multiple myeloma
Kawano, Y., Moschetta, M., Manier, S., Glavey, S. V., Görgün, G., Roccaro, A. M., Anderson, K. C., & Ghobrial, I. M. (2014) · Immunological Reviews · doi:10.1111/imr.12233 · Cited by 394
Fu, Y., Liu, S., Zeng, S., & Shen, H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1396-4 · Cited by 395
Huang, R., Francois, A., McGray, A. R., Miliotto, A. J., & Odunsi, K. O. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1249561 · Cited by 395
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Fujita, M., Kohanbash, G., Fellows-Mayle, W. K., Hamilton, R. L., Komohara, Y., Decker, S. A., Ohlfest, J. R., & Okada, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3055 · Cited by 386
Tumor Purity as an Underlying Key Factor in Glioma
Zhang, C., Cheng, W., Ren, X., Wang, Z., Liu, X., Li, G., Han, S., Jiang, T., & Wu, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2598 · Cited by 377
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Li, X., Shao, C., Shi, Y., & Han, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0578-4 · Cited by 389
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 454
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Allavena, P., & Mantovani, A. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04515.x · Cited by 399
Poschke, I. C., Mougiakakos, D., Hansson, J., Masucci, G. V., & Kiessling, R. W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3767 · Cited by 381
Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106939 · Cited by 397
TNF signaling drives myeloid-derived suppressor cell accumulation
Zhao, X., Rong, L., Zhao, X., Li, X., Liu, X., Deng, J., Wu, H., Xu, X., Erben, U., Wu, P., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64115 · Cited by 389
Ouzounova, M., Lee, E., Piranlioglu, R., Andaloussi, A. E., Kolhe, R. B., Demirci, M. F., Marasco, D., Asm, I., Chadli, A., Hassan, K. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14979 · Cited by 378
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Ziani, L., Chouaïb, S., & Thiery, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00414 · Cited by 391
Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C. A., Hirschhorn-Cymerman, D., Avogadri, F., Rizzuto, G. A., Lazarus, J. J., Pamer, E. G., Houghton, A. N., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1792 · Cited by 380
Schmid, M. C., Avraamides, C. J., Dippold, H. C., Franco, I., Foubert, P., Ellies, L. G., Acevedo, L. M., Manglicmot, J. R. E., Song, X., Wrasidlo, W., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.016 · Cited by 378
Pillay, J., Tak, T., Kamp, V. M., & Koenderman, L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1286-4 · Cited by 376
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Alfaro, C., Sanmamed, M. F., Rodriguez-Ruiz, M. E., Teijeira, Á., Oñate, C., González, Á., Ponz‐Sarvisé, M., Schalper, K. A., Perez‐Gracia, J. L., & Melero, I. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.004 · Cited by 380
Orillion, A., Hashimoto, A., Damayanti, N., Shen, L., Adelaiye-Ogala, R., Arisa, S., Chintala, S., Ordentlich, P., Kao, C., Elzey, B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0741 · Cited by 373
Self-citationYan, H. H., Pickup, M. W., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 379
Transcriptional regulation of myeloid-derived suppressor cells
Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 382
Self-citationLoeuillard, E. J., Yang, J., Buckarma, E. H., Wang, J., Liu, Y., Conboy, C. B., Pavelko, K. D., Li, Y., O’Brien, D. R., Wang, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137110 · Cited by 376
Kumar, V., Cheng, P., Condamine, T., Mony, S., Languino, L. R., McCaffrey, J. C., Hockstein, N., Guarino, M., Masters, G., Penman, E., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.014 · Cited by 371
Self-citationCellular Constituents of Immune Escape within the Tumor Microenvironment
Kerkar, S. P., & Restifo, N. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4094 · Cited by 383
Prados‐Rosales, R., Baena, A., Martinez, L. R., Luque-Garcia, J. L., Kalscheuer, R., Usha, V., Cámara, C., Nosanchuk, J. D., Besra, G. S., Chen, B., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44261 · Cited by 376
Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W. C., Kato, M., Prévost‐Blondel, A., Thiery, J. P., & Abastado, J. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001162 · Cited by 386
Solinas, G., Schiarea, S., Liguori, M., Fabbri, M., Pesce, S., Zammataro, L. A., Pasqualini, F., Nebuloni, M., Chiabrando, C., Mantovani, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000413 · Cited by 373
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Писарев, В. М., Sherman, S., Sporn, M. B., & Gabrilovich, D. I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45862 · Cited by 377
Self-citationInsights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases
Li, S., Hong, M., Tan, H., Wang, N., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4234061 · Cited by 368
The metastasis-promoting roles of tumor-associated immune cells
Smith, H. A., & Kang, Y. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1021-5 · Cited by 380
Chemokines in health and disease
Raman, D., Sobolik-Delmaire, T., & Richmond, A. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.005 · Cited by 387
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
“In the third and final way, MDSCs are able to enhance Treg cell differentiation to disrupt anti-cancer immunity [172, 351 T c e ll s [ 316 ] T a b l e 2 N a n o p a r t i c l e - m e d i a t e d T c e ll r e g u l a t i o n i n c a n c e r t h e r a p y function of the immune system [352, 353].”
BackgroundRen, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z.-R., Roberts, A. I., Zhang, L., Zheng, H. B., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.08.013 · Cited by 370
Raychaudhuri, B., Rayman, P. A., Ireland, J. L., Ko, J. S., Rini, B. I., Borden, E. C., Garcia, J., Vogelbaum, M. A., & Finke, J. H. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor042 · Cited by 361
Dendritic cell control of tolerogenic responses
Manicassamy, S., & Pulendran, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01015.x · Cited by 366
Bone marrow and the control of immunity
Zhao, E., Xu, H., Wang, L., Kryczek, I., Wu, K., Hu, Y., Wang, G., & Zou, W. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.47 · Cited by 367
High-dimensional analysis of the murine myeloid cell system
Becher, B., Schlitzer, A., Chen, J.-M., Mair, F., Sumatoh, H., Teng, K., Low, D., Ruedl, C., Riccardi-Castagnoli, P., Poidinger, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.3006 · Cited by 357
Immunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 368
Plubell, D. L., Wilmarth, P. A., Zhao, Y., Fenton, A. M., Minnier, J., Reddy, A. P., Klimek, J. E., Yang, X., David, L. L., & Pamir, N. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065524 · Cited by 338
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
Kim, T. K., Vandsemb, E. N., Herbst, R. S., & Chen, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00493-5 · Cited by 361
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Kuo, C., Babuharisankar, A. P., Lin, Y., Lien, H., Lo, Y. K., Chou, H.-Y., Tangeda, V., Cheng, L.-C., Cheng, A. N., & Lee, A. Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00859-2 · Cited by 367
Priceman, S. J., Sung, J. L., Shaposhnik, Z., Burton, J. B., Torres‐Collado, A. X., Moughon, D. L., Johnson, M., Lusis, A. J., Cohen, D. A., Iruela‐Arispe, M. L., et al. (2009) · Blood · doi:10.1182/blood-2009-08-237412 · Cited by 370
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Programming dendritic cells to induce TH2 and tolerogenic responses
Pulendran, B., Tang, H., & Manicassamy, S. (2010) · Nature Immunology · doi:10.1038/ni.1894 · Cited by 358
Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments
Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 389
“107 More importantly, when macrophages express CSF-1R, tumor cells secrete M-CSF to attract TAMs, 108 and after TAMs are attracted to tumor cells, they secrete EGF, which activates the epidermal growth factor receptor (EGFR) signaling pathway in tumor cells, and the activation of the EGFR pathway…”
InfluentialZhang, H., & Grizzle, W. E. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.027 · Cited by 357
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., & Wang, P. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1110765 · Cited by 387
Wang, J., Li, D., Cang, H., & Guo, B. (2019) · Cancer Medicine · doi:10.1002/cam4.2327 · Cited by 363
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression
Chen, L., Huang, L., Gu, Y. L., Cang, W., Sun, P., & Xiang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911943 · Cited by 380
Youn, J. I., Kumar, V., Collazo, M. M., Nefedova, Y., Condamine, T., Cheng, P., Villagra, A., Antonia, S. J., McCaffrey, J. C., Fishman, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2526 · Cited by 359
Self-citationS100A8/A9 activate key genes and pathways in colon tumor progression
Ichikawa, M., Williams, R., Wang, L., Vogl, T., & Srikrishna, G. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0394 · Cited by 346
Meyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108121108 · Cited by 352
Al-Khami, A. A., Zheng, L., Valle, L. D., Hossain, F. M., Wyczechowska, D. D., Zabaleta, J., Sanchez‐Pino, M. D., Dean, M. J., Rodrı́guez, P. C., & Ochoa, A. C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1344804 · Cited by 357
Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
Barrett, R. L., & Puré, E. (2020) · eLife · doi:10.7554/elife.57243 · Cited by 357
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X., Wei, Y.-Q., & Wei, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 352
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Kerkar, S. P., Goldszmid, R. S., Muranski, P. J., Chinnasamy, D., Yu, Z., Reger, R. N., Leonardi, A. J., Morgan, R. A., Wang, E., Marincola, F. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58814 · Cited by 340
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.003 · Cited by 343
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Xia, A., Zhang, Y., Jiang, X., Yin, T., & Lu, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 344
A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma
Cuenca, A. G., Delano, M. J., Kelly‐Scumpia, K. M., Moreno, C. R. D. C., Scumpia, P. O., LaFace, D., Heyworth, P. G., Efron, P. A., & Moldawer, L. L. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00178 · Cited by 340
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Zhou, J., Nefedova, Y., Lei, A., & Gabrilovich, D. I. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.004 · Cited by 354
Self-citationRébé, C., & Ghiringhelli, F. (2020) · Cancers · doi:10.3390/cancers12071791 · Cited by 351
Adrover, J. M., McDowell, S. A. C., He, X., Quail, D. F., & Egeblad, M. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.001 · Cited by 365
Tumor-associated macrophages: an effective player of the tumor microenvironment
Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., & Sa, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295257 · Cited by 356
Sweeney, T. E., Shidham, A., Wong, H. R., & Khatri, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5993 · Cited by 346
Tumor-Associated Neutrophils in Cancer: Going Pro
Wu, L., Saxena, S., Awaji, M. I., & Singh, R. K. (2019) · Cancers · doi:10.3390/cancers11040564 · Cited by 348
Solito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S., Basso, G., Zanovello, P., Onicescu, G., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325753 · Cited by 345
The Role of Macrophages in Cancer Development and Therapy
Cendrowicz, E., Sas, Z., Bremer, E., & Rygiel, T. P. (2021) · Cancers · doi:10.3390/cancers13081946 · Cited by 332
Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., LINKE, R. P., Müller, M. M., Blander, J. M., Tacke, F., & Trautwein, C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091474 · Cited by 346
Flores‐Toro, J., Luo, D., Gopinath, A., Sarkisian, M. R., Campbell, J. J., Charo, I. F., Singh, R., Schall, T. J., Datta, M., Jain, R. K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910856117 · Cited by 330
Eosinophils in health and disease: the LIAR hypothesis
Lee, J. J., Jacobsen, E. A., McGarry, M. P., Schleimer, R. P., & Lee, N. A. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03484.x · Cited by 343
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Ohl, K., & Tenbrock, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02499 · Cited by 340
Cicco, P. D., Ercolano, G., & Ianaro, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01680 · Cited by 341
He, D., Li, H., Yusuf, N., Elmets, C. A., Li, J., Mountz, J. D., & Xu, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902574 · Cited by 350
Kim, I. S., Gao, Y., Welte, T., Wang, H., Liu, J., Janghorban, M., Sheng, K., Niu, Y., Goldstein, A., Zhao, N., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0373-7 · Cited by 340
Microenvironmental Determinants of Pancreatic Cancer
Heßmann, E., Buchholz, S., Demir, İ. E., Singh, S. K., Gress, T. M., Ellenrieder, V., & Neeße, A. (2020) · Physiological Reviews · doi:10.1152/physrev.00042.2019 · Cited by 336
Macrophage Polarization in Health and Disease
Cassetta, L., Cassol, E., & Poli, G. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/213962 · Cited by 347
Yuan, J. D., Adamow, M. J., Ginsberg, B. A., Rasalan, T. S., Ritter, E., Gallardo, H. F., Xu, Y., Pogoriler, E., Terzulli, S. L., Kuk, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110814108 · Cited by 337
Mondanelli, G., Bianchi, R., Pallotta, M. T., Orabona, C., Albini, E., Iacono, A., Belladonna, M. L., Vacca, C., Fallarino, F., Macchiarulo, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.005 · Cited by 338
Metadata
- Authors
- Gabrilovich, D. I., & Nagaraj, S.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Gabrilovich, Dmitry I.
- Venue
- Nature Reviews Immunology
- Published
- 2009-03
- Volume
- 9
- Issue
- 3
- Pages
- 162-174
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2828349
- OpenAlex
- W2004150448
- Cited by
- 6,753
- References
- 133
- Citations by year
- 2026: 267 · 2025: 335 · 2024: 384 · 2023: 418 · 2022: 488 · 2021: 537 · 2020: 498 · 2019: 384 · 2018: 433 · 2017: 409 · 2016: 405 · 2015: 422 · 2014: 403 · 2013: 430 · 2012: 378
- FWCI
- 24.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Repositorio Institucional E-DocUR (Universidad Del Rosario) (submittedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- myeloid-derived suppressor cells, T cell suppression, tumor immunosuppression, inflammation, infection, immune regulation
- MeSH terms
- Animals, Cell Movement, Communicable Diseases, Humans, Immune System, Immune Tolerance, Inflammation, Lymphocyte Activation, Neoplasms, Stem Cells, T-Lymphocytes, Myeloid Cells, Myelopoiesis, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
